ADAR1 Capital Management »

Aimfinity Investment Corp I shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Aimfinity Investment Corp I (AIMAW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Aimfinity Investment Corp I

Tip: Access up to 7 years of quarterly data

All positions including Aimfinity Investment Corp I held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aimfinity Investment Corp I by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $675 18k 0.04

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Aimfinity Investment Corp I

Hudson Bay Capital Management
Spartan Fund Management
State of Wisconsin Investment Board
CNH Partners
Cubist Systematic Strategies
Polar Securities
Whitebox Advisors
Cowen And Company
Ionic Capital Management
Cable Car Capital
Tudor Investment Corporation
Context Capital Management
Saba Capital Management
Walleye Trading Advisors
III Capital Management

View all funds holding Aimfinity Investment Corp I